关于高级管理人员减持计划实施完成的公告 证券代码：300290 证券简称：荣科科技 公告编号：2026-005 荣科科技股份有限公司 公司高管刘斌先生保证向本公司提供的信息内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 荣科科技股份有限公司（以下简称公司）于2026年2月3日在指定媒体巨潮资讯 网（http://www.cninfo.com.cn）披露了《高级管理人员减持股份预披露公告》，公司 高级管理人员刘斌计划自预披露公告发布之日起15个交易日后的3个月内拟通过集 中竞价交易方式减持不超过公司股份47,600股股份。具体事项详见公司于巨潮资讯 网披露的相关信息。 近日，公司收到高管刘斌先生出具的《关于股份减持计划实施完成告知函》， 其减持计划已实施完成。现将具体情况公告如下： 一、股东减持股份情况 关于高级管理人员减持计划实施完成的公告 1 关于高级管理人员减持计划实施完成的公告 | 1、减持计划实施情况 | | --- | | 股东名称 | 减持方式 | | 减持期间 | | | 减持均价（元/股） | 减持股数（股） | ...

Group 1 - The core viewpoint of the news highlights the recent trading performance and financial metrics of Rongke Technology, indicating a slight increase in stock price and notable financing activities [1] - On February 25, Rongke Technology's stock rose by 2.20%, with a trading volume of 350 million yuan, and a net financing purchase of 4.66 million yuan [1] - As of February 25, the total margin balance for Rongke Technology was 944 million yuan, accounting for 8.36% of its market capitalization, which is below the 40th percentile level over the past year, indicating a low financing level [1] Group 2 - As of September 30, the number of shareholders for Rongke Technology decreased by 10.80% to 54,000, while the average circulating shares per person increased by 12.10% to 11,834 shares [2] - For the period from January to September 2025, Rongke Technology reported a revenue of 454 million yuan, a year-on-year decrease of 4.49%, and a net profit attributable to shareholders of -31.69 million yuan, representing a significant decline of 378.82% [2] - Since its A-share listing, Rongke Technology has distributed a total of 99.14 million yuan in dividends, with no dividends paid in the last three years [2]

Core Viewpoint - The company has appointed Lixin Certified Public Accountants (Special General Partnership) as the auditing firm for its 2025 fiscal year, with the audit report expected to be released on April 24, 2026 [1] Group 1 - The company will provide updates on the audit report through official announcements [1] - The appointment of the auditing firm is part of the company's compliance and governance practices [1]

Core Viewpoint - The company focuses on the smart healthcare sector, aiming for high-quality development through product iteration, market expansion, cost optimization, and resource integration [2] Group 1: Business Strategy - The company is enhancing its profitability by improving its product offerings in AI medical record quality control, emergency critical care, and closing data loops for perioperative care [2] - The company supports intelligent review of medical insurance DRG/DIP and intelligent triage and guidance as part of its product strategy [2] Group 2: Market Focus - The company plans to strengthen regional market collaboration to improve profitability as a core objective [2] - The company commits to regularly disclosing significant business progress to protect the rights of all shareholders [2]

Group 1 - The company confirmed that there are no undisclosed matters or related plans, discussions, or agreements that need to be disclosed according to the Shenzhen Stock Exchange's listing rules [2] - The statement was made in response to investor inquiries on the company's interactive platform [2] - The announcement regarding abnormal stock trading fluctuations was published on January 9, 2026 [2]

Core Viewpoint - Rongke Technology (300290) is focusing on "AI + healthcare" strategic layout and aims to improve performance by optimizing costs and receivables in 2026 [1] Group 1 - The company is committed to enhancing profitability through capital operations that align with its development strategy, with any plans to be disclosed in compliance with regulations [1] - As of February 11, 2026, the company’s Secretary reiterated that there are currently no significant matters to disclose, including asset restructuring or cross-industry merger plans [1]

Core Viewpoint - Rongke Technology (300290) is optimizing its financial structure and enhancing investor returns by addressing accumulated losses in compliance with the new Company Law and relevant financial regulations [1] Group 1 - The company is focusing on its core business development while implementing loss compensation as a compliant financial optimization strategy [1] - The actions taken are aimed at improving the company's financial health and ensuring long-term returns for investors [1] - The company emphasizes that the loss compensation is a necessary step under the premise of compliance [1]

Group 1 - The core viewpoint of the article is that Rongke Technology (300290.SZ) is actively engaging in business activities through its subsidiary, Zhiwei Cloud, which focuses on market promotion and project implementation of super fusion servers and related products in the Northeast region [1] - Zhiwei Cloud is currently a super fusion platinum dealer, indicating its strategic positioning in the market [1] - The company is expanding its business into medical and government sectors, showcasing its diversification efforts [1]

Core Viewpoint - The company is utilizing 556 million yuan from its reserve fund to cover losses, which aligns with the new Company Law and aims to optimize its financial statements and clear obstacles for future development [1] Group 1 - The use of reserve funds to cover losses is a compliant operation under the new Company Law and relevant financial regulations [1] - This financial optimization strategy is intended to enhance the company's financial health and improve returns for investors [1] - The company remains focused on its core business development while using loss coverage as a means of financial optimization [1] Group 2 - The company expresses gratitude for investor interest and emphasizes its commitment to long-term value creation [1] - There is an implication that the company will provide further details on how it plans to leverage its improved financial structure for profit distribution, refinancing, or core business investments in the future [1]

Core Viewpoint - The collaboration between the company's subsidiary and Super Fusion is perceived as a potential positive development by the market, prompting inquiries about the specifics of the partnership, including scale, profit contribution expectations, duration, and future expansion plans [1] Group 1: Company Collaboration Details - The company confirmed that its subsidiary, Zhihuiyun, is currently a platinum distributor for Super Fusion, focusing on the Northeast region [1] - The collaboration aims to promote Super Fusion servers and related products in medical and governmental scenarios [1] - This type of business cooperation is categorized as a normal commercial activity for the company [1]